Result entries:  6813
DRACP ID Peptide Name Sequence Sequence Length Origin
DRACP01381 Sequence 57 from Patent US 20110319336 MEPVDPRLEPWKHPGSQPKTACTNCYCKKCCFHCQVCFITKALGISYGRKKRRQRRRAHQNSQTHQASLSKQPTSQPRGDPTGPKE 86 Synthetic construct
DRACP01382 Sequence 5 from Patent US 20110319336 MQLPLAT 7 Synthetic construct
DRACP01383 Sequence 29 from Patent US 20110319336 NYQWVPYQGRVPYPR 15 Synthetic construct
DRACP01384 Sema3A(aa363-377) -kLytic NYQWVPYQGRVPYPRGGGKLLLKLLKKLLKlLKKK 35 Synthetic
DRACP01385 Sequence 20 from Patent US 20110319336 NYQWVPYQGRVPYPRGGGKLLLKLLKKLLKLLKKK 35 Synthetic construct
DRACP01386 Sema3A(aa363-377) -nLytic NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL 32 Synthetic
DRACP01387 Sequence 13 from Patent US 20110319336 RLLRRLLRRLLRK 13 Synthetic construct
DRACP01388 Sequence 12 from Patent US 20110319336 RLLRRLLRRLLRRLLRRLLR 20 Synthetic construct
DRACP01389 Sequence 58 from Patent US 20110319336 RQIKIQFQNRRMKWKK 16 Synthetic construct
DRACP01390 Sequence 25 from Patent US 20110319336 RQIKIQFQNRRMKWKKKAYARIGNSYFK 28 Synthetic construct
DRACP01391 Sequence 38 from Patent US 20110319336 SNEW 4 Synthetic construct
DRACP01392 Sequence 34 from Patent US 20110319336 THRPPMWSPVWP 12 Synthetic construct
DRACP01393 Tfr-lytic THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK 32 Synthetic
DRACP01394 Sequence 32 from Patent US 20110319336 VEPNCDIHVMWEWECFERL 19 Synthetic construct
DRACP01395 Sequence 39 from Patent US 20110319336 WDLAWMFRLPVG 12 Synthetic construct
DRACP01396 Sequence 31 from Patent US 20110319336 WHSDMEWWYLLG 12 Synthetic construct
DRACP01397 Sequence 16 from Patent US 20110319336 WHSDMEWWYLLGGGGKLlLKlLkkLLKlLKKK 32 Synthetic construct
DRACP01398 Sequence 55 from Patent US 20110319336 WTGWCLNPEESTWGFCTGSF 20 Synthetic construct
DRACP01399 Sequence 30 from Patent US 20110319336 YCDGFYACYMDV 12 Synthetic construct
DRACP01400 Sequence 15 from Patent US 20110319336 YCDGFYACYMDVGGGKLlLKlLkkLLKlLKKK 32 Synthetic construct
DRACP01401 Sequence 7 from Patent US 20110319336 YHWYGYTPQNVI 12 Synthetic construct
DRACP01402 Sequence 21 from Patent US 20110319336 YHWYGYTPQNVIGGGGGRLLRRLLRRLLRK 30 Synthetic construct
DRACP01403 EB-lytic YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK 32 Synthetic
DRACP01404 Sequence 42 from Patent US 20110319336 YHWYGYTPQNVIGGGLLkLLKklLKKLlKL 30 Synthetic construct
DRACP01405 Sequence 10 from Patent US 20110319336 YKWYGYTPQNVI 12 Synthetic construct
DRACP01406 Sequence 9 from Patent US 20110319336 YRWYGYTPQNVI 12 Synthetic construct
DRACP01407 EB(H2R)-lytic YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK 32 Synthetic
DRACP01408 Sequence 6 from Patent US 20120302729 CQDLFGRAPSKAVNPDEA 18 Synthetic construct
DRACP01409 Sequence 9 from Patent US 20120302729 DLFGR 5 Synthetic construct
DRACP01410 Sequence 11 from Patent US 20120302729 DLFGRAP 7 Synthetic construct
<< < 45 46 47 48 49 >>

DRACP is developed by Dr.Zheng's team.